Skip to main content
. Author manuscript; available in PMC: 2021 May 10.
Published in final edited form as: J Control Release. 2020 Jan 29;321:272–284. doi: 10.1016/j.jconrel.2020.01.051

FIG. 7.

FIG. 7.

Comparison of the cytokine expression changes after UTMD treatment alone or UTD-mediated miRNA drug delivery. Cytokine expressions were assessed in (A) tumors, (B) tumor-associated lymph nodes (tumor lymph nodes) and (C) serum of tumor-bearing mice (tumor serum) prior to treatment (0 h) and 0.5, 6, and 24 h after treatment with UTMD-mediated delivery of miR-122-/anti-miR-21-loaded NPs. For statistical analysis, all treated samples were compared to the untreated control.